RFK Jr. Seeks To Accelerate Approvals for Lower-Cost Generic Alternatives to Expensive Biologic Drugs

The proposal could cut in half the time and cost of approval of new generics.

Packaging for AbbVie's biologic drug, Humira. — Packaging for AbbVie's biologic drug, Humira. AP/David J. Phillip

LUKE FUNK

Published: Oct 29, 2025, 03:53 PM ET
Updated:Oct 29, 2025, 05:30 PM ET